These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 8849246)
1. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Doern GV; Ferraro MJ; Brueggemann AB; Ruoff KL Antimicrob Agents Chemother; 1996 Apr; 40(4):891-4. PubMed ID: 8849246 [TBL] [Abstract][Full Text] [Related]
2. [Susceptibility to penicillin and 13 antimicrobial agents in erythromycin-resistant viridans group streptococci isolated from blood cultures]. Rodríguez-Avial C; Rodríguez-Avial I; Picazo JJ Rev Esp Quimioter; 2001 Sep; 14(3):275-80. PubMed ID: 11753449 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Doern GV; Brueggemann A; Holley HP; Rauch AM Antimicrob Agents Chemother; 1996 May; 40(5):1208-13. PubMed ID: 8723468 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of viridans group streptococci. Tuohy M; Washington JA Diagn Microbiol Infect Dis; 1997 Dec; 29(4):277-80. PubMed ID: 9458986 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. Teng LJ; Hsueh PR; Chen YC; Ho SW; Luh KT J Antimicrob Chemother; 1998 Jun; 41(6):621-7. PubMed ID: 9687100 [TBL] [Abstract][Full Text] [Related]
6. In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Potgieter E; Carmichael M; Koornhof HJ; Chalkley LJ Eur J Clin Microbiol Infect Dis; 1992 Jun; 11(6):543-6. PubMed ID: 1526239 [TBL] [Abstract][Full Text] [Related]
7. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group. Pfaller MA; Jones RN; Marshall SA; Edmond MB; Wenzel RP Diagn Microbiol Infect Dis; 1997 Dec; 29(4):259-63. PubMed ID: 9458983 [TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia. Gosbell IB; Fernandes LA; Fernandes CJ Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725 [TBL] [Abstract][Full Text] [Related]
9. Antibiotic susceptibility of clinical isolates of Streptococcus pneumoniae. Traub WH; Leonhard B Chemotherapy; 1996; 42(4):240-7. PubMed ID: 8804790 [TBL] [Abstract][Full Text] [Related]
10. Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases. Ergin A; Eser ÖK; Hasçelik G New Microbiol; 2011 Apr; 34(2):187-93. PubMed ID: 21617831 [TBL] [Abstract][Full Text] [Related]
11. Viridans streptococci in infective endocarditis: species distribution and susceptibility to antibiotics. Horaud T; Delbos F Eur Heart J; 1984 Oct; 5 Suppl C():39-44. PubMed ID: 6519085 [TBL] [Abstract][Full Text] [Related]
12. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. Alcaide F; Carratala J; Liñares J; Gudiol F; Martin R Antimicrob Agents Chemother; 1996 Sep; 40(9):2117-20. PubMed ID: 8878591 [TBL] [Abstract][Full Text] [Related]
13. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs. Traub WH; Leonhard B Chemotherapy; 1997; 43(2):123-31. PubMed ID: 9084921 [TBL] [Abstract][Full Text] [Related]
14. [Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood]. Rodríguez-Avial C; García MM; Rodríguez-Avial I; Picazo JJ Rev Esp Quimioter; 1999 Dec; 12(4):346-51. PubMed ID: 10855014 [TBL] [Abstract][Full Text] [Related]
15. Susceptibility of sixty-five non-oral clinical isolates of the Streptococcus milleri group to seven antimicrobial agents. Horton WA; Drucker DB; Jacob AE; Hillier VF Microbios; 1992; 71(287):125-34. PubMed ID: 1453983 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents. Smith A; Jackson MS; Kennedy H Scand J Infect Dis; 2004; 36(4):259-63. PubMed ID: 15198181 [TBL] [Abstract][Full Text] [Related]
17. In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada. de Azavedo JC; Trpeski L; Pong-Porter S; Matsumura S; Low DE Antimicrob Agents Chemother; 1999 Sep; 43(9):2299-301. PubMed ID: 10471583 [TBL] [Abstract][Full Text] [Related]
18. [Viridans streptococci in human infections: identification and susceptibility to antibiotics]. Horodniceanu T; Delbos F Ann Microbiol (Paris); 1982; 133(2):255-69. PubMed ID: 7149526 [TBL] [Abstract][Full Text] [Related]
19. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. Wisplinghoff H; Reinert RR; Cornely O; Seifert H J Clin Microbiol; 1999 Jun; 37(6):1876-80. PubMed ID: 10325340 [TBL] [Abstract][Full Text] [Related]
20. In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Alcaide F; Liñares J; Pallares R; Carratala J; Benitez MA; Gudiol F; Martin R Antimicrob Agents Chemother; 1995 Oct; 39(10):2243-7. PubMed ID: 8619576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]